SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

4D Pharma plc – ‘F-4/A’ on 1/8/21 – ‘EX-23.2’

On:  Friday, 1/8/21, at 4:33pm ET   ·   Accession #:  1104659-21-2497   ·   File #:  333-250986

Previous ‘F-4’:  ‘F-4’ on 11/25/20   ·   Next:  ‘F-4/A’ on 1/28/21   ·   Latest:  ‘F-4/A’ on 2/24/21   ·   11 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/08/21  4D Pharma plc                     F-4/A                  7:12M                                    Toppan Merrill/FA

Pre-Effective Amendment to Registration Statement by a Foreign Issuer – Securities for a Merger   —   Form F-4
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: F-4/A       Pre-Effective Amendment to Registration Statement   HTML   3.05M 
                by a Foreign Issuer - Securities for a Merger                    
 2: EX-9.2      Voting Trust Agreement                              HTML     42K 
 3: EX-10.1     Material Contract                                   HTML     81K 
 5: EX-10.11    Material Contract                                   HTML     15K 
 4: EX-10.2     Material Contract                                   HTML    290K 
 6: EX-23.1     Consent of Expert or Counsel                        HTML      6K 
 7: EX-23.2     Consent of Expert or Counsel                        HTML      6K 


‘EX-23.2’   —   Consent of Expert or Counsel


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

Exhibit 23.2

 

Independent Registered Public Accounting Firm’s Consent

 

We consent to the inclusion in this Registration Statement of 4D Pharma on Amendment No. 1 to Form F-4 File No. 333-250986, of our report dated April 30, 2020, with respect to our audits of the financial statements of Longevity Acquisition Corp. as of February 29, 2020 and February 28, 2019 and for the years ended, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.

 

 

/s/ Marcum llp

 

Marcum llp

New York, NY

January 8, 2021

 

 C: 

 C:  

 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘F-4/A’ Filing    Date    Other Filings
Filed on:1/8/21CORRESP
4/30/20
2/29/20
2/28/19
 List all Filings 


10 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/31/22  4D Pharma plc                     20-F       12/31/21   82:13M                                    M2 Compliance LLC/FA
10/07/21  4D Pharma plc                     F-1/A                 90:15M                                    M2 Compliance LLC/FA
 9/14/21  4D Pharma plc                     F-1         9/13/21   76:9.2M                                   M2 Compliance LLC/FA
 4/30/21  4D Pharma plc                     20-F/A     12/31/20   75:6.9M                                   M2 Compliance LLC/FA
 4/23/21  4D Pharma plc                     F-1                   73:8.4M                                   M2 Compliance LLC/FA
 4/02/21  4D Pharma plc                     20-F       12/31/20   77:7.1M                                   M2 Compliance LLC/FA
 2/24/21  4D Pharma plc                     F-4/A                  4:11M                                    Toppan Merrill/FA
 2/19/21  4D Pharma plc                     F-4/A                  4:11M                                    Toppan Merrill/FA
 2/16/21  4D Pharma plc                     F-4/A                 12:12M                                    Toppan Merrill/FA
 1/28/21  4D Pharma plc                     F-4/A                 17:100M                                   Toppan Merrill/FA


1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/25/20  4D Pharma plc                     F-4                    8:12M                                    Toppan Merrill/FA
Top
Filing Submission 0001104659-21-002497   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 1, 6:36:02.1am ET